SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
What is the latest Contingent Liabilities ratio of SAMRAT PHARMACHEM ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.07 Cr |
Mar2023 | ₹0.07 Cr |
Mar2022 | ₹0.07 Cr |
Mar2021 | ₹0.07 Cr |
Mar2020 | ₹0.07 Cr |
How is Contingent Liabilities of SAMRAT PHARMACHEM Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.07 Cr | 0.00 | |
Mar2023 | ₹0.07 Cr | 0.00 | |
Mar2022 | ₹0.07 Cr | 0.00 | |
Mar2021 | ₹0.07 Cr | 0.00 | |
Mar2020 | ₹0.07 Cr | - |
Compare Contingent Liabilities of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹108.3 Cr | -5.6% | -3.3% | 1.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,635.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,685.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -5.6% |
-3.3% |
1.5% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses